Modern Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Modern Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10M	Sell	40,407 -1,384	-3%	-$298K	0.12%	183
2026 Q1	$8.46M	Buy	41,791 +213	+0.5%	+$44.1K	0.14%	152
2025 Q4	$8.59M	Buy	41,578 +496	+1%	+$99.1K	0.16%	142
2025 Q3	$7.37M	Sell	41,082 -948	-2%	-$161K	0.15%	150
2025 Q2	$6.78M	Buy	42,030 +11,907	+40%	+$1.9M	0.17%	131
2025 Q1	$5.12M	Buy	30,123 +307	+1%	+$53.3K	0.16%	121
2024 Q4	$4.96M	Buy	+29,816	New	+$5.09M	0.19%	109

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Modern Wealth Management's FBT Position: Q2 2026 in Review

Modern Wealth Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3.3% in Q2 2026, selling an estimated $298K and leaving 40,407 shares worth $10M. The position accounts for 0.12% of the portfolio, ranked #183.

Modern Wealth Management first reported a position in FBT in Q4 2024 and has held it in 7 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Modern Wealth Management held 40,407 shares of First Trust NYSE Arca Biotechnology Index Fund worth $10M as of Q2 2026.
Modern Wealth Management sold 1,384 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $298K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.12% of Modern Wealth Management's portfolio in Q2 2026, its #183 holding.
Modern Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and has held it in 7 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.